Current status of cytokine-induced killer cells and combination regimens in breast cancer
Breast cancer remains a significant health challenge worldwide, with substantial efforts aimed at understanding its pathogenesis, biological characteristics, and clinical triggers. Recently, immunotherapy such as the cytokine-induced killer cells combined with other drug therapies has offered new ho...
Saved in:
| Main Authors: | Yuancong Jiang, Jie Qiu, Nanwei Ye, Yingchun Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1476644/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment outcome in a patient with triple-negative breast cancer using adoptive immunotherapy
by: E. V. Abakushina, et al.
Published: (2025-07-01) -
Combined immunotherapy with dendritic cells and cytokine-induced killer cells for solid tumors: a systematic review and meta-analysis of randomized controlled trials
by: Wendi Jiang, et al.
Published: (2024-12-01) -
Inhibition of human gastric cancer growth by cytokine-induced killer cells plus chemotherapy with or without cadonilimab in a mouse xenograft tumor model
by: Wenwei Yang, et al.
Published: (2025-06-01) -
Natural killer cell memory: challenges and opportunities for cancer immunotherapy
by: Yuhua Qu, et al.
Published: (2024-12-01) -
ADOPTIVE CELL THERAPY: CURRENT ADVANCES
by: T. V. Shamova, et al.
Published: (2020-03-01)